Loading clinical trials...
Loading clinical trials...
Blinded Randomized Controlled Trial of Artificial Intelligence Guided Assessment of Cardiac Function
To determine whether an integrated AI decision support can save time and improve accuracy of assessment of echocardiograms, the investigators are conducting a blinded, randomized controlled study of AI guided measurements of left ventricular ejection fraction compared to sonographer measurements in preliminary readings of echocardiograms.
Age
18 - 110 years
Sex
ALL
Healthy Volunteers
No
Cedars-Sinai Medical Center
Los Angeles, California, United States
Start Date
April 1, 2022
Primary Completion Date
June 29, 2022
Completion Date
June 29, 2022
Last Updated
July 5, 2022
3,495
ACTUAL participants
Automated annotation of the left ventricle through deep learning
OTHER
Sonographer Measurement of LVEF
OTHER
Lead Sponsor
Cedars-Sinai Medical Center
NCT07199088
NCT06332391
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT04636892